Automated Method to Track E.Coli
Researchers from Purdue University Calumet have turned to a simple, automated method of tracking E.coli.
Researchers from Purdue University Calumet have turned to a simple, automated method of tracking E.coli.
Researchers at Imperial College London have discovered a protein that triggers rheumatoid arthritis.
Researchers from Victoria University have found that cigarettes contain a number of addictive elements within the tar, in addition to the commonly cited nicotine.
The Juvenile Diabetes Research Foundation will team up with Animas Corporation, a subsidiary of Johnson and Johnson, to create an “artificial pancreas,” the diabetes charity has announced.
A study by researchers from the Kimmel Cancer Center at Jefferson says that the “longevity” protein SIRT1 can inhibit the development of a known precursor to prostate cancer. .
A new device can detect severe heart attacks in more patients, leading to better diagnoses and faster treatment, according to new research. The new 80-lead electrocardiogram (ECG/EKG), PRIME ECG, can give physicians a broader reading of the heart muscle than the traditional 12-lead ECG.
Three new fat removal technologies that are awaiting approval from the US Food and Drug Administration should be available to patients by 2011.
Health Sciences Online has launched a website where anyone can access more than 50,000 courses, references, guidelines, and other expert-reviewed, high-quality, current, cost-free, and ad-free health sciences resources.
Researchers have recently discovered that a protein Nrf2 plays a vital role in some antioxidant therapies and also promotes atherosclerosis – clogging of arteries.
A research from UC Davis Cancer Center has revealed that a person screening for colon cancer often depends on where they live in addition to their race or ethnicity.
A study says that over-the-counter painkillers, used for treating inflammation, can increase the risk of heart attacks and strokes.
Scientists at Inserm and Institut Pasteur has developed a prognostic test that can predict the efficacy of hepatitis C treatments has been developed. The commercialisation of the test is expected in 2011.
A report by Global Industry Analysts say that the global market for ECG telemetry devices is estimated to reach $1.1bn by 2015.